Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MHEART: Aspirin for Cardiovascular Risk in HIV Patients on ART
NCT02401269Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Apr 2015
- Primary completion
- Jan 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in cardiovascular disease (CVD), sponsored by University of Pittsburgh. Started Apr 2015; status: completed.
02
Drugs
aspirin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02401269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02401269.